Filing Flows › Alpha Teknova (TKNO) › Q1 2025
Alpha Teknova (TKNO) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Alpha Teknova (TKNO) reported revenue of $9.8M for the first quarter 2025 (Q1 2025), +5% from a year earlier and +6% from the quarter before. Operating margin was -50.7%, net loss $4.6M (47.4% of revenue).
Alpha Teknova, Q1 2025: revenue $9.8M (+5% year over year), operating margin -50.7%, net loss $4.6M, operating cash flow −$4.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.8M | +6% | +5% |
| Operating profit | −$5.0M | — | — |
| Net earnings | −$4.6M | — | — |
| Operating cash flow | −$4.1M | — | — |
What changed
Revenue was $9.8M in Q1 2025, up 5% year over year and up 6% from the previous quarter. Lab Essentials was the largest line at 83% of revenue. Lab Essentials added $851K year over year (up 12%), 169% of the total change. Clinical Solutions declined 32%.
Gross margin was 30.7%, up 6.9 points from a year earlier. Operating costs exceeded revenue by $5.0M, an operating margin of -50.7%. Operating expenses fell 22% while revenue rose 5%. The quarter ended with a net loss of $4.6M, narrower than the previous quarter's $5.7M loss.
Operating cash flow was −$4.1M. Non-cash charges added back $1.6M of depreciation and amortization and $852K of share-based compensation. Working capital and other items used $1.9M. Capital expenditures of $206K exceeded it, leaving free cash flow of −$4.3M.
Questions
What was Alpha Teknova's revenue in the first quarter 2025?
Alpha Teknova (TKNO) reported revenue of $9.8M for the first quarter 2025 (Q1 2025), +5% from a year earlier and +6% from the quarter before.
Was Alpha Teknova profitable in the first quarter 2025?
Operating loss was $5.0M (-50.7% of revenue) and net loss $4.6M.
Source: Alpha Teknova 10-Q on SEC EDGAR.